SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-040976
Filing Date
2019-07-03
Accepted
2019-07-03 15:31:38
Documents
1
Period of Report
2019-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3853
  Complete submission text file 0001209191-19-040976.txt   5364
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL SUITE 325 CHARLOTTE NC 28277
Business Address
Clemens Kevan (Reporting) CIK: 0001316737 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 19941727